<p>EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression</p>

Dongwei Dou(First Affiliated Hospital of Zhengzhou University), Mingli Han(First Affiliated Hospital of Zhengzhou University)
OncoTargets and Therapy
November 1, 2019
10.2147/ott.s214104
Cited by 34

Related Papers

Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN
|PLoS ONE|2012|243
RETRACTED ARTICLE: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation
|Molecular Cancer|2020|192
RETRACTED: Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway
|Frontiers in Immunology|2020|172
RETRACTED: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation
|Frontiers in Oncology|2020|29